Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.85, $0.13 better than the analyst estimate of $0.72. Revenue for the quarter came in at $396.7 million versus the consensus estimate of $382.51 million.

GUIDANCE:

Phibro Animal Health sees FY2027 EPS of $3.41-$3.59, versus the consensus of $3.07. Phibro Animal Health sees FY2027 revenue of $1.55-1.6 billion, versus the consensus of $1.49 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.